The impact of the United States (U.S.) foreign aid cuts on the health and well-being of people who use drugs has been massive and monumental. Not unlike the impacts felt across health, development, and humanitarian sectors around the world, the abrupt withdrawal of U.S. foreign aid has resulted in significant disruption to core harm reduction services, HIV/Hepatitis C (HCV) programming, and commodity supplies for people who use drugs globally. None of the U.S. administration’s rescinded programme terminations, or U.S. waivers, have applied to harm reduction programming or to HIV/ HCV services for people who use drugs. To date, no alternative solutions have been put in place to ensure the continuity of and equitable access to rights-based harm reduction services and HIV/ HCV prevention, treatment, and care for people who use drugs. We are being erased from the HIV and HCV response...